Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Boyle

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Oncology Reports|August 17, 2011
Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphomaEileen M Boyle, Franck Morschhauser
Best Practice & Research. Clinical Haematology|March 7, 2020
Monitoring minimal residual disease in the bone marrow using next generation sequencingEven H Rustad, Eileen M Boyle
Cancer Journal (Sudbury, Mass.)|September 22, 2021
From Bench to Bedside: The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple MyelomaGareth J Morgan, Eileen M Boyle, Faith E Davies
Best Practice & Research. Clinical Haematology|March 7, 2020
Reconstructing the evolutionary history of multiple myelomaFrancesco Maura, Even H Rustad, Eileen M Boyle, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
The evolving role and utility of off-label drug use in multiple myelomaJames H Stoeckle, Faith E Davies, Louis Williams, et al.
Leukemia Research Reports|May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone sizeCeline Berthon, Morgane Nudel, Eileen M Boyle, et al.
Musculoskeletal Science & Practice|September 4, 2022
Patient perspectives of care pathways for people with low back pain: A qualitative studyEileen M Boyle, Robyn E Fary, Samantha Lee, et al.
Physiotherapy Theory and Practice|November 4, 2022
Patient experiences of referral practices and primary care physiotherapy for chronic nonspecific low back painEileen M Boyle, Kerrie Evans, Sonia Coates, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Scientific Reports|March 27, 2021
A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myelomaKwan Yeung Wong, Gareth J Morgan, Eileen M Boyle, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|August 17, 2011
Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphomaEileen M Boyle, Franck Morschhauser
Best Practice & Research. Clinical Haematology|March 7, 2020
Monitoring minimal residual disease in the bone marrow using next generation sequencingEven H Rustad, Eileen M Boyle
Cancer Journal (Sudbury, Mass.)|September 22, 2021
From Bench to Bedside: The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple MyelomaGareth J Morgan, Eileen M Boyle, Faith E Davies
Best Practice & Research. Clinical Haematology|March 7, 2020
Reconstructing the evolutionary history of multiple myelomaFrancesco Maura, Even H Rustad, Eileen M Boyle, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
The evolving role and utility of off-label drug use in multiple myelomaJames H Stoeckle, Faith E Davies, Louis Williams, et al.
Leukemia Research Reports|May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone sizeCeline Berthon, Morgane Nudel, Eileen M Boyle, et al.
Musculoskeletal Science & Practice|September 4, 2022
Patient perspectives of care pathways for people with low back pain: A qualitative studyEileen M Boyle, Robyn E Fary, Samantha Lee, et al.
Physiotherapy Theory and Practice|November 4, 2022
Patient experiences of referral practices and primary care physiotherapy for chronic nonspecific low back painEileen M Boyle, Kerrie Evans, Sonia Coates, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Scientific Reports|March 27, 2021
A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myelomaKwan Yeung Wong, Gareth J Morgan, Eileen M Boyle, et al.
Pageof 6